- Home
- FNKO vs OABI Comparison
FNKO vs OABI Comparison
Compare FNKO & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- OABI
- Stock Information
- Founded
- FNKO 2017
- OABI 2012
- Country
- FNKO United States
- OABI United States
- Employees
- FNKO N/A
- OABI N/A
- Industry
- FNKO Recreational Games/Products/Toys
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- FNKO Consumer Discretionary
- OABI Health Care
- Exchange
- FNKO Nasdaq
- OABI Nasdaq
- Market Cap
- FNKO 225.8M
- OABI 198.2M
- IPO Year
- FNKO 2017
- OABI N/A
- Fundamental
- Price
- FNKO $4.85
- OABI $1.60
- Analyst Decision
- FNKO Buy
- OABI Strong Buy
- Analyst Count
- FNKO 4
- OABI 3
- Target Price
- FNKO $9.88
- OABI $7.00
- AVG Volume (30 Days)
- FNKO 1.2M
- OABI 1.2M
- Earning Date
- FNKO 08-07-2025
- OABI 08-07-2025
- Dividend Yield
- FNKO N/A
- OABI N/A
- EPS Growth
- FNKO N/A
- OABI N/A
- EPS
- FNKO N/A
- OABI N/A
- Revenue
- FNKO $1,024,890,000.00
- OABI $26,744,000.00
- Revenue This Year
- FNKO N/A
- OABI N/A
- Revenue Next Year
- FNKO $9.22
- OABI $45.65
- P/E Ratio
- FNKO N/A
- OABI N/A
- Revenue Growth
- FNKO N/A
- OABI 27.07
- 52 Week Low
- FNKO $3.50
- OABI $1.22
- 52 Week High
- FNKO $14.65
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- FNKO 55.06
- OABI 54.70
- Support Level
- FNKO $4.72
- OABI $1.35
- Resistance Level
- FNKO $5.39
- OABI $1.81
- Average True Range (ATR)
- FNKO 0.32
- OABI 0.10
- MACD
- FNKO 0.05
- OABI 0.04
- Stochastic Oscillator
- FNKO 68.35
- OABI 71.96
About FNKO Funko Inc.
Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.